Le Lézard
Classified in: Health
Subjects: SCZ, FVT

Emanate Health to Host "Aging Well & Younger Next Year" Seminar, Oct. 12, to Promote Senior Health & Wellness

COVINA, Calif., Sept. 18, 2019 /PRNewswire/ -- Emanate Health, the largest health care system in the San Gabriel Valley, will host the "Aging Well & Younger Next Year" Seminar, on October 12, 2019, at the Pacific Palms Resort in the City of Industry. Leading medical experts will provide attendees with the latest tips to aging well including sexual health, Joint care, memory, vitamins and supplements and much more.

(PRNewsfoto/Emanate Health)

"It's important that our community is well in body, mind and spirit, especially because 16.55 percent of our community is comprised of seniors 65+," said Emanate Health President & CEO Rob Curry. "The 'Aging Well & Younger Next Year' Seminar provides seniors with important tools to remain healthy, along with access to free blood pressure screenings."

Top health care experts representing Emanate Health, as well as Cedar-Sinai Medical Center, Keck School of Medicine of USC and the UC Irvine School of Medicine, will address subjects that will benefit the health and wellness of seniors. Event registration and a continental breakfast begin at 7:30 a.m. followed by the opening session at 8:30 a.m. A full lunch is also included in the admission price.

"Although seniors may face chronic health challenges, the impact of many of these ailments can be managed with a doctor's care and treatment," said Emanate Health Chief Medical Officer Gurjeet Kalkat, MD. "The panel of medical experts will offer fresh, medical insights that will help to educate and empower seniors to take charge of their health."   

 "Aging Well & Younger Next Year" Seminar speakers include:

The cost to attend is $20 for those age 55+ and other community members are invited. Attendees will also have the opportunity to participate in raffles, giveaways and more. Health care professionals can receive up to six continuing education credits. For additional information, call 888.456.2847 or visit emanatehealth.org/agingwell/

About Emanate Health
Emanate Health, emanatehealth.org, is the largest nonprofit health care provider serving the one million residents of the San Gabriel Valley in California. The system provides specialized care in Behavioral Health, Cancer, Cardiovascular, Emergency, Neuroscience and Stroke, Orthopedics, Sports Medicine, and Women's Health. Its family of hospitals and hospice include Emanate Health Foothill Presbyterian in Glendora, Emanate Health Inter-Community in Covina, and Emanate Health Queen of the Valley in West Covina, Emanate Health Hospice and Emanate Health Home Care in West Covina, as well as other clinics throughout the region. Year after year the health care system has been voted "Best Hospital" and "Best Place to Work" and providers are consistently among the "Top Doctors" in Los Angeles County and hospitals are graded A for Patient Safety by The Leapfrog Group. Visit emanatehealth.org, our Newsroom and connect with us on LinkedIn ?Twitter ? Instagram ? Facebook.


SOURCE Emanate Health

These press releases may also interest you

at 14:30
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Baxter International Inc. between February 21, 2019 and October 23, 2019, inclusive (the "Class Period") of the important January 24, 2020 lead plaintiff...

at 14:05
Kite, a Gilead Company , today announced new data from the ZUMA-1 trial of Yescarta® (axicabtagene ciloleucel) in adult patients with refractory large B-cell lymphoma. These results included updated overall survival data from the pivotal phase 2...

at 14:05
bluebird bio, Inc. announced new data from its ongoing Phase 1/2 HGB-206 study of investigational LentiGlobintm gene therapy for sickle cell disease (SCD), including additional patients treated in the study and updated data for those previously...

at 14:05
Aleta Biotherapeutics, a privately held immunotherapy company focused on transforming cellular therapeutics to allow a broad spectrum of cancer indications to be targeted, today presented in vitro and in vivo results demonstrating that Aleta's novel...

at 14:05
Seattle Genetics, Inc. today announced updated and long-term follow-up analyses from two clinical trials evaluating ADCETRIS (brentuximab vedotin) and OPDIVO® (nivolumab) in frontline Hodgkin lymphoma (HL) patients aged 60 years and older and in...

at 14:05
Bristol-Myers Squibb Company today announced the pivotal study of lisocabtagene maraleucel (liso-cel) an investigational CD19-directed CAR T-cell therapy with a defined composition of purified CD8+ and CD4+ CAR T cells in relapsed/refractory large...

News published on 18 september 2019 at 18:33 and distributed by: